When it comes to the share price, you’re correct, it’s disappointing for current holders. Fair price remains $0.175-$0.19 based on my extensive fundamentals and technical analysis.
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-424
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.8¢ | 18.0¢ | $14.78K | 79.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 386830 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 2351 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |